End-of-day quote
Saudi Arabian S.E.
06:00:00 2024-04-27 pm EDT
|
5-day change
|
1st Jan Change
|
317
SAR
|
+0.63%
|
|
+0.70%
|
+11.62%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
38,150
|
56,490
|
77,210
|
99,400
|
110,250
|
-
|
-
|
Enterprise Value (EV)
1 |
38,150
|
56,609
|
77,663
|
101,963
|
116,093
|
116,166
|
117,366
|
P/E ratio
|
36.1
x
|
41.1
x
|
46.7
x
|
48.5
x
|
50.6
x
|
40.4
x
|
34.8
x
|
Yield
|
1.38%
|
1.67%
|
-
|
-
|
1.2%
|
1.73%
|
1.75%
|
Capitalization / Revenue
|
6.51
x
|
7.79
x
|
9.29
x
|
10.5
x
|
9.58
x
|
7.47
x
|
7.05
x
|
EV / Revenue
|
6.51
x
|
7.81
x
|
9.34
x
|
10.7
x
|
10.1
x
|
7.87
x
|
7.51
x
|
EV / EBITDA
|
26.6
x
|
31.8
x
|
38.6
x
|
42.3
x
|
40.9
x
|
33.2
x
|
28.9
x
|
EV / FCF
|
26.9
x
|
60.9
x
|
58.4
x
|
-403
x
|
151
x
|
53.6
x
|
36.5
x
|
FCF Yield
|
3.72%
|
1.64%
|
1.71%
|
-0.25%
|
0.66%
|
1.87%
|
2.74%
|
Price to Book
|
7.77
x
|
10.6
x
|
13.1
x
|
15.3
x
|
15.5
x
|
13.9
x
|
12.3
x
|
Nbr of stocks (in thousands)
|
350,000
|
350,000
|
350,000
|
350,000
|
350,000
|
-
|
-
|
Reference price
2 |
109.0
|
161.4
|
220.6
|
284.0
|
315.0
|
315.0
|
315.0
|
Announcement Date
|
2/21/21
|
2/20/22
|
2/21/23
|
2/20/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
5,862
|
7,250
|
8,311
|
9,508
|
11,513
|
14,756
|
15,636
|
EBITDA
1 |
1,433
|
1,781
|
2,010
|
2,408
|
2,841
|
3,498
|
4,062
|
EBIT
1 |
1,115
|
1,466
|
1,700
|
2,096
|
2,291
|
2,981
|
3,448
|
Operating Margin
|
19.02%
|
20.22%
|
20.46%
|
22.04%
|
19.9%
|
20.2%
|
22.05%
|
Earnings before Tax (EBT)
1 |
1,128
|
1,491
|
1,797
|
2,170
|
2,430
|
3,036
|
3,655
|
Net income
1 |
1,055
|
1,377
|
1,651
|
2,046
|
2,326
|
2,805
|
3,220
|
Net margin
|
18.01%
|
18.99%
|
19.86%
|
21.52%
|
20.2%
|
19.01%
|
20.59%
|
EPS
2 |
3.020
|
3.930
|
4.720
|
5.850
|
6.220
|
7.800
|
9.053
|
Free Cash Flow
1 |
1,420
|
929.3
|
1,330
|
-252.7
|
770
|
2,167
|
3,218
|
FCF margin
|
24.23%
|
12.82%
|
16.01%
|
-2.66%
|
6.69%
|
14.69%
|
20.58%
|
FCF Conversion (EBITDA)
|
99.14%
|
52.18%
|
66.19%
|
-
|
27.11%
|
61.95%
|
79.2%
|
FCF Conversion (Net income)
|
134.57%
|
67.5%
|
80.59%
|
-
|
33.11%
|
77.26%
|
99.92%
|
Dividend per Share
2 |
1.500
|
2.700
|
-
|
-
|
3.787
|
5.456
|
5.500
|
Announcement Date
|
2/21/21
|
2/20/22
|
2/21/23
|
2/20/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
---|
Net sales
1 |
1,836
|
1,968
|
1,991
|
2,014
|
2,052
|
2,254
|
2,307
|
2,272
|
2,443
|
2,486
|
2,580
|
EBITDA
|
-
|
-
|
498.7
|
-
|
-
|
505.3
|
-
|
577
|
-
|
-
|
-
|
EBIT
1 |
380.5
|
396.3
|
422.1
|
414.7
|
436.1
|
427.6
|
510.6
|
498.8
|
552.1
|
534.2
|
548.5
|
Operating Margin
|
20.72%
|
20.13%
|
21.2%
|
20.59%
|
21.25%
|
18.97%
|
22.13%
|
21.95%
|
22.6%
|
21.48%
|
21.26%
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
1 |
348.6
|
383.6
|
390.5
|
398.1
|
420.6
|
441.5
|
489.3
|
487
|
544.8
|
491
|
533.3
|
Net margin
|
18.98%
|
19.49%
|
19.61%
|
19.77%
|
20.5%
|
19.59%
|
21.21%
|
21.43%
|
22.3%
|
19.75%
|
20.67%
|
EPS
|
1.000
|
1.090
|
-
|
-
|
1.200
|
1.260
|
1.400
|
1.390
|
1.560
|
1.500
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
10/24/21
|
2/20/22
|
4/24/22
|
8/7/22
|
10/23/22
|
2/21/23
|
5/7/23
|
8/6/23
|
10/30/23
|
2/20/24
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
119
|
453
|
2,563
|
5,843
|
5,916
|
7,116
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
0.0667
x
|
0.2255
x
|
1.064
x
|
2.057
x
|
1.691
x
|
1.752
x
|
Free Cash Flow
1 |
1,420
|
929
|
1,330
|
-253
|
770
|
2,167
|
3,218
|
ROE (net income / shareholders' equity)
|
22.7%
|
26.9%
|
29.4%
|
33.1%
|
30.9%
|
35.7%
|
37.2%
|
ROA (Net income/ Total Assets)
|
11.8%
|
13.6%
|
14.1%
|
14.4%
|
15.6%
|
17.5%
|
19.3%
|
Assets
1 |
8,974
|
10,154
|
11,706
|
14,191
|
14,955
|
16,000
|
16,684
|
Book Value Per Share
2 |
14.00
|
15.30
|
16.80
|
18.50
|
20.40
|
22.70
|
25.50
|
Cash Flow per Share
2 |
-
|
-
|
-
|
9.270
|
7.200
|
8.700
|
11.10
|
Capex
1 |
758
|
1,254
|
1,513
|
3,497
|
4,200
|
1,403
|
988
|
Capex / Sales
|
12.93%
|
17.29%
|
18.21%
|
36.78%
|
36.48%
|
9.51%
|
6.32%
|
Announcement Date
|
2/21/21
|
2/20/22
|
2/21/23
|
2/20/24
|
-
|
-
|
-
|
Average target price
291.6
SAR Spread / Average Target -7.43% Consensus |
1st Jan change
|
Capi.
|
---|
| +10.92% | 29.4B | | -14.92% | 84.68B | | +13.30% | 81.12B | | -12.71% | 16.73B | | -3.06% | 16.36B | | -2.63% | 14.92B | | -31.75% | 11.77B | | -1.42% | 11.72B | | +27.44% | 11.71B | | -3.97% | 11.66B |
Other Healthcare Facilities & Services
|